LILLY ENDOWMENT INCLILLY ENDOWMENT INC

Institutional investor · Portfolio as of Q3 2019

SEC EDGAR SourceSEC Filings
$13B
AUM
1
Positions
Q3 2019
Filing
Rating · 1.5
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q3'19
New0%Increased0%Decreased100%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.0 quarters
<1Q0%1-4Q100%1-2Y0%2Y+0%

LILLY ENDOWMENT INC manages $13B across 1 positions as of Q3 2019. Top holdings: LLY (100.0%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q3 2019 Summary

Trimmed 1. No standout high-conviction moves this quarter. Portfolio: $13.0B across 1 positions.

Top holdings by portfolio weight

Total AUM$13B
LLY100.00%

Portfolio allocation by GICS sector

Sectors1
Healthcare100.00%

Behavioral investing profile

Concentrated Value67%- primarily Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record0
Conviction34
Concentration0
Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Upgrade to Pro to see the worst-performing positions.

View plans

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Holdings1 positions

Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ELI LILLY & CO

116.6M$13B100.0%$118.50-12.43%
3 qtrssince 2019-Q1
Decreased
0

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used